Bilobalide protects H9c2 cell from oxygen-glucose-deprivation-caused damage through upregulation of miR-27a
Ailin Cao, Xiangting Li
Journal:Artificial Cells Nanomedicine and Biotechnology
IF:4.46
DOI:10.1080/21691401.2019.1640708
PMID:
Published:2019-12-01
research field:分子生物学细胞信号传导药理学心血管研究
Abstract
Abstract We, the Editors and Publisher of the journal Artificial Cells, Nanomedicine, and Biotechnology, have retracted the following article: Ailin Cao and Xiangting Li. (2019). Bilobalide protects H9c2 cell from oxygen-glucose-deprivation-caused damage through upregulation of miR-27a. Artificial Cells, Nanomedicine, and Biotechnology. 47:1, 2980–2988, DOI: 10.1080/21691401.2019.1640708 Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors have been unable to verify their original data. The authors have agreed to retract the article. We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
本文使用的Yeasen产品


